Author

Francesco Picardo

Observed names: F. Picardo, Picardo, Francesco

Institutions: Menarini Group (Italy), Menarini Silicon Biosystems (Italy)

Observed institutions: Università Campus Bio-Medico, Menarini Group (Italy), University Medical Center Hamburg-Eppendorf, Campus Bio Medico University Hospital, Menarini Silicon Biosystems (Italy)

ORCID: 0000-0002-9820-1745

Observed ORCID: 0000-0002-9820-1745

OpenAlex ID: A5064289987

Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma

2017 · Federico Pio Fabrizio, Manuela Costantini, et al. · Oncotarget · 92

Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients

2017 · Raffaela Barbano, Barbara Pasculli, et al. · Scientific Reports · 56

Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer

2019 · Francesco Picardo, Antonella Romanelli, et al. · Cancers · 38

Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases

2018 · Uyen-Thao Le, Peter Bronsert, et al. · Scientific Reports · 19

Abstract 2397: Epigenetic silencing in clear renal cell carcinoma: KEAP1 promoter hypermethylation

2017 · Federico Pio Fabrizio, Manuela Costantini, et al. · Cancer Research · 5

Abstract 3364: Combined enrichment of plasma EpCAM-positive extracellular vesicles (EVs) and circulating tumor cells (CTCs) from a single tube of cancer patient blood samples, for subsequent molecular analysis

2023 · Giulia Bregola, Martina Masotti, et al. · Cancer Research · 1

Abstract 4734: miR-9-5p expression in breast cancer correlates with hormone receptor status and affects patients survival

2017 · Raffaela Barbano, Barbara Pasculli, et al. · Cancer Research · 1

MT21 Clinical Application of Circulating Tumor Cells in Melanoma Patients: Overview of Current Available Data

2023 · F. de Snoo, A. Lucci, et al. · Value in Health

MT37 Clinical Utility of Circulating Tumor Cell (CTC) Enumeration-Based Liquid Biopsy and HER2 CTC Assessment in Patients with Metastatic Breast Cancer: Overview of Current Available Data and Interventional Trials

2023 · M. Cristofanilli, F. de Snoo, et al. · Value in Health

Comparison of Tumor-associated miRNAs in EpCAM+, CD47+ and CD29+ Extracellular Vesicles (EVs) Immunomagnetically Enriched From Cancer Patients’ Plasma

2023 · G. Bregola, M. Masotti, et al. · The Journal of Liquid Biopsy

CO119 Clinical Utility of Circulating Tumor Cell Enumeration-Based Liquid Biopsy in Patients with Metastatic Breast Cancer: A Review of the Peer-Reviewed Clinical Literature

2023 · M. Cristofanilli, F. de Snoo, et al. · Value in Health

Pos0424 Determining Circulating Endothelial Cells Using Cellsearch System in Systemic Sclerosis Patients

2021 · F. Pignataro, L. Zorzino, et al. · Annals of the Rheumatic Diseases

Author Correction: Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases

2020 · Uyen-Thao Le, Peter Bronsert, et al. · Scientific Reports

Works count: 14

Citation count: 212

H-index: 5

I10-index: 4